Indian pharma major manufacturing generics, complex generics, biosimilars and APIs, sold in 100+ countries.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 91 | 91 | 91 | 91 | 91 | 91 | 91 | 91 |
| Reserves | 17.4k | 18.5k | 18.1k | 18.3k | 20.5k | 24.2k | 19.5k | 30.0k |
| Borrowings | 6 | 485 | 951 | 749 | 105 | 250 | 6.2k | 1.1k |
| Other Liabilities | 3.2k | 2.8k | 3.2k | 3.5k | 4.2k | 3.9k | 7.7k | 4.9k |
| Total Liabilities | 20.7k | 21.9k | 22.3k | 22.7k | 24.9k | 28.4k | 33.5k | 36.1k |
| AssetsFixed Assets | 3.5k | 3.6k | 3.7k | 4.0k | 4.1k | 4.9k | 10.3k | 4.9k |
| CWIP | 822 | 951 | 947 | 927 | 446 | 278 | 593 | 523 |
| Investments | 7.5k | 9.6k | 9.5k | 10.0k | 11.6k | 12.0k | 3.3k | 15.6k |
| Other Assets | 8.9k | 7.7k | 8.2k | 7.8k | 8.8k | 11.3k | 19.3k | 15.1k |
| Total Assets | 20.7k | 21.9k | 22.3k | 22.7k | 24.9k | 28.4k | 33.5k | 36.1k |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
LUPIN · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.